Matches in UGent Biblio for { <https://biblio.ugent.be/publication/5764390#aggregation> ?p ?o. }
Showing items 1 to 41 of
41
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B1016205.
- aggregation creator B1016206.
- aggregation creator B1016207.
- aggregation creator B1016208.
- aggregation creator B1016209.
- aggregation creator B1016210.
- aggregation creator B1016211.
- aggregation creator B1016212.
- aggregation creator B1016213.
- aggregation creator person.
- aggregation date "2014".
- aggregation format "application/pdf".
- aggregation hasFormat 5764390.bibtex.
- aggregation hasFormat 5764390.csv.
- aggregation hasFormat 5764390.dc.
- aggregation hasFormat 5764390.didl.
- aggregation hasFormat 5764390.doc.
- aggregation hasFormat 5764390.json.
- aggregation hasFormat 5764390.mets.
- aggregation hasFormat 5764390.mods.
- aggregation hasFormat 5764390.rdf.
- aggregation hasFormat 5764390.ris.
- aggregation hasFormat 5764390.txt.
- aggregation hasFormat 5764390.xls.
- aggregation hasFormat 5764390.yaml.
- aggregation isPartOf urn:issn:0195-668X.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial".
- aggregation abstract "The EUROACTION PLUS trial measured the effectiveness of a nurse-led preventive cardiology programme (EUROACTION) offering intensive smoking cessation PLUS optional varenicline for persistent high CVD risk smokers to reduce overall cardiovascular risk compared with usual care (UC) in general practice (GP). A parallel group randomized controlled trial in 20 GP in Italy, Netherlands, Spain, and UK. Six hundred and ninety-six current smokers, (137 vascular disease and 559 high total CVD risk), were randomized 350 to EUROACTION PLUS (EA+) and 346 to UC. Specially, trained nurses offered the EUROACTION preventive cardiology programme addressing smoking cessation, diet, physical activity, and risk factor management to reduce overall cardiovascular risk. The primary endpoint was 7 day point prevalence of self-reported abstinence (validated breath carbon monoxide < 10 p.p.m.) at 16 weeks. Secondary outcomes included dietary habits, physical activity, weight, blood pressure (BP), lipid, and glucose management. One hundred and seventy-seven (51%) EA+ patients (91% opted to use varenicline) were abstinent vs. 63 (19%) in UC; OR 4.52 (95% CI: 3.20-6.39). The Mediterranean diet score of a parts per thousand yen9 in 149 (52%) EA+ patients vs. 97 (37%) in UC; OR 1.84 (95% CI: 1.31-2.59). Physical activity target achieved in 46 (16%) EA+ patients vs. 19 (7%) in UC; OR 2.48 (95% CI: 1.41-4.36). Target BP (< 140/90 mm Hg) achieved in 150 (52%) EA+ patients vs. 112 (43%) in UC, OR 1.47 (95% CI: 1.05-2.06) with no difference in antihypertensive drugs. There were no differences in management of cholesterol or glucose. The EUROACTION preventive cardiology programme in high CVD risk smokers using optional varenicline substantially increased smoking abstinence over 16 weeks and also reduced overall cardiovascular risk compared with UC. REC reference: 09/H0402/85; EudraCT number: 2009-012451-18; , 12 February 2014, date last accessed.".
- aggregation authorList BK1426794.
- aggregation endPage "1420".
- aggregation issue "21".
- aggregation startPage "1411".
- aggregation volume "35".
- aggregation aggregates 5764493.
- aggregation isDescribedBy 5764390.
- aggregation similarTo ehu051.
- aggregation similarTo LU-5764390.